Statistics

Total Visits

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study16

Select a period of time:

Number of views in the range

Views
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study6

Views

Views
May 20240
June 20240
July 20243
August 20241
September 20241
October 20241
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
Spain1
 

Top cities views

Views
DeKalb1
Prineville1